Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
July-2020 Volume 46 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2020 Volume 46 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells

  • Authors:
    • Yoshiaki Tabuchi
    • Keita Maekawa
    • Misako Torigoe
    • Yukihiro Furusawa
    • Tetsushi Hirano
    • Satsuki Minagawa
    • Tatsuya Yunoki
    • Atsushi Hayashi
  • View Affiliations / Copyright

    Affiliations: Division of Molecular Genetics Research, Life Science Research Center, University of Toyama, Toyama 930‑0194, Japan, Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930‑0194, Japan, Department of Liberal Arts and Sciences, Toyama Prefectural University, Toyama 939‑0398, Japan
    Copyright: © Tabuchi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 58-66
    |
    Published online on: April 28, 2020
       https://doi.org/10.3892/ijmm.2020.4591
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Hyperthermia (HT) is considered to be of value as a treatment modality in various cancers. However, the acquisition of thermotolerance in cancer cells due to the induction of heat shock proteins (HSPs) makes HT less effective. Recent findings have indicated that heat shock protein nuclear import factor hikeshi (HIKESHI), also referred to as C11orf73, acts as a nuclear import carrier of Hsp70 under heat stress conditions. The aim of the present study was to determine whether knockdown (KD) of HIKESHI by small interfering RNA (siRNA) can potentiate mild HT (MHT) sensitivity in human oral squamous cell carcinoma (OSCC) HSC‑3 cells. The mRNA and protein expression of HIKESHI was found to be markedly suppressed in HSC‑3 cells treated with siRNA for HIKESHI (siHIKE). Silencing HIKESHI significantly decreased the cell viability under MHT conditions (42˚C for 90 min). Immunocytochemical and western blot analyses clearly demonstrated that Hsp70 protein translocated from the cytoplasm to the nucleus under MHT conditions, and this translocation was significantly inhibited in cells treated with siHIKE. Treatment of the cells with MHT transiently increased the phosphorylation level of extracellular signal‑regulated kinase (ERK)2. Furthermore, the phosphorylation was sustained in HIKESHI‑KD cells under MHT conditions, and this sustained phosphorylation was abolished by pretreatment with U0126, an inhibitor of mitogen‑activated protein kinase/ERK. In addition, U0126 significantly decreased the viability of cells treated with the combination of HIKESHI‑KD and MHT. The data of the present study suggest that HIKESHI silencing enhanced the sensitivity of human OSCC HSC‑3 cells to MHT.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

van der Zee J, González González D, van Rhoon GC, van Dijk JD, van Putten WL and Hart AA: Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 355:1119–1125. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R and Schlag PM: Hyperthermia in combined treatment of cancer. Lancet Oncol. 3:487–497. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Issels RD: Hyperthermia adds to chemotherapy. Eur J Cancer. 44:2546–2554. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR and Jones EL: Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: A review of the randomised data. Int J Hyperthermia. 26:612–617. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Westermann A, Mella O, Van Der Zee J, Jones EL, Van Der Steen-Banasik E, Koper P, Uitterhoeve AL, De Wit R, Van Der Velden J, Burger C, et al: Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyper-thermia-an update. Int J Hyperthermia. 28:549–553. 2012. View Article : Google Scholar

6 

Ahmed K, Tabuchi Y and Kondo T: Hyperthermia: An effective strategy to induce apoptosis in cancer cells. Apoptosis. 20:1411–1419. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Ohguri T, Harima Y, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M and Terashima H: Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: Data from a multicentre randomised clinical trial. Int J Hyperthermia. 34:461–468. 2018. View Article : Google Scholar

8 

Bakker A, van der Zee J, van Tienhoven G, Kok HP, Rasch CRN and Crezee H: Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: A systematic review. Int J Hyperthermia. 36:1024–1039. 2019. View Article : Google Scholar : PubMed/NCBI

9 

Tohnai I, Hayashi Y, Mitsudo K, Shigetomi T, Ueda M and Ishigaki T: Prognostic evaluation of preoperative thermochemo-radiotherapy for N(3) cervical lymph node metastases of oral cancer. Oncology. 62:234–240. 2002. View Article : Google Scholar

10 

Nozato T, Koizumi T, Hayashi Y, Iida M, Iwai T, Oguri S, Hirota M, Kioi M, Koike I, Hata M, et al: Thermochemora-diotherapy using superselective intra-arterial infusion for patients with oral cancer with cervical lymph node metastases. Anticancer Res. 39:1365–1373. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Urano M: Kinetics of thermotolerance in normal and tumor tissues: A review. Cancer Res. 46:474–482. 1986.PubMed/NCBI

12 

Sapareto SA: Thermal isoeffect dose: Addressing the problem of thermotolerance. Int J Hyperthermia. 3:297–305. 1987. View Article : Google Scholar : PubMed/NCBI

13 

Overgaard J: The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys. 16:535–549. 1989. View Article : Google Scholar : PubMed/NCBI

14 

Li GC, Mivechi NF and Weitzel G: Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. Int J Hyperthermia. 11:459–488. 1995. View Article : Google Scholar : PubMed/NCBI

15 

Li GC and Calderwood SK: Hyperthermia classic article commentary: 'Re-induction of hsp70 synthesis: An assay for thermotolerance' by Gloria C. Li and Johnson Y. Mak, International Journal of Hyperthermia 1989;5:389-403. Int J Hyperthermia. 25:258–261. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Lindquist S and Craig EA: The heat-shock proteins. Annu Rev Genet. 22:631–677. 1988. View Article : Google Scholar : PubMed/NCBI

17 

Ohtsuka K and Hata M: Molecular chaperone function of mammalian Hsp70 and Hsp40-a review. Int J Hyperthermia. 16:231–245. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Hartl FU and Hayer-Hartl M: Molecular chaperones in the cytosol: From nascent chain to folded protein. Science. 295:1852–1858. 2002. View Article : Google Scholar : PubMed/NCBI

19 

Kregel KC: Heat shock proteins: Modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 1985. 92:2177–2186. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B and Hightower LE: Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 14:105–111. 2009. View Article : Google Scholar :

21 

Akerfelt M, Morimoto RI and Sistonen L: Heat shock factors: Integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol. 11:545–555. 2010. View Article : Google Scholar : PubMed/NCBI

22 

Fujimoto M and Nakai A: The heat shock factor family and adaptation to proteotoxic stress. FEBS J. 277:4112–4125. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Calderwood SK and Asea A: Targeting HSP70-induced thermo-tolerance for design of thermal sensitizers. Int J Hyperthermia. 18:597–608. 2002. View Article : Google Scholar

24 

McMillan DR, Xiao X, Shao L, Graves K and Benjamin IJ: Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J Biol Chem. 273:7523–7528. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Tabuchi Y, Furusawa Y, Wada S, Ohtsuka K and Kondo T: Silencing heat shock transcription factor 1 using small interfering RNA enhances mild hyperthermia and hyperthermia sensitivity in human oral squamous cell carcinoma cells. Thermal Med. 27:99–108. 2011. View Article : Google Scholar

26 

Bettaieb A and Averill-Bates DA: Thermotolerance induced at a mild temperature of 40°C alleviates heat shock-induced ER stress and apoptosis in HeLa cells. Biochim Biophys Acta. 1853:52–62. 2015. View Article : Google Scholar

27 

Matozaki M, Saito Y, Yasutake R, Munira S, Kaibori Y, Yukawa A, Tada M and Nakayama Y: Involvement of Stat3 phosphorylation in mild heat shock-induced thermotolerance. Exp Cell Res. 377:67–74. 2019. View Article : Google Scholar : PubMed/NCBI

28 

Pelham HR: Hsp70 accelerates the recovery of nucleolar morphology after heat shock. EMBO J. 3:3095–3100. 1984. View Article : Google Scholar : PubMed/NCBI

29 

Welch WJ and Feramisco JR: Nuclear and nucleolar localization of the 72,000-dalton heat shock protein in heat-shocked mammalian cells. J Biol Chem. 259:4501–4513. 1984.PubMed/NCBI

30 

Kose S, Furuta M and Imamoto N: Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage. Cell. 149:578–589. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Rahman KMZ, Mamada H, Takagi M, Kose S and Imamoto N: Hikeshi modulates the proteotoxic stress response in human cells: Implication for the importance of the nuclear function of HSP70s. Genes Cells. 22:968–976. 2017. View Article : Google Scholar : PubMed/NCBI

32 

Yanoma T, Ogata K, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Yanai M, Kogure N, Kimura A, Suzuki M, et al: Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70. Oncol Rep. 38:1500–1506. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Bhalla S, Chaudhary K, Kumar R, Sehgal M, Kaur H, Sharma S and Raghava GP: Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer. Sci Rep. 7:449972017. View Article : Google Scholar : PubMed/NCBI

34 

Tabuchi Y, Wada S, Furusawa Y, Ohtsuka K and Kondo T: Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells. Int J Mol Med. 29:380–386. 2012.

35 

Yunoki T, Kariya A, Kondo T, Hayashi A and Tabuchi Y: The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells. Cancer Lett. 335:52–57. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Yunoki T, Tabuchi Y, Hayashi A and Kondo T: Network analysis of genes involved in the enhancement of hyperthermia sensitivity by the knockdown of BAG3 in human oral squamous cell carcinoma cells. Int J Mol Med. 38:236–242. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Suzuki K, Bose P, Leong-Quong RY, Fujita DJ and Riabowol K: REAP: A two minute cell fractionation method. BMC Res Notes. 3:2942010. View Article : Google Scholar : PubMed/NCBI

38 

Chang KL, Wong LR, Pee HN, Yang S and Ho PC: Reverting metabolic dysfunction in cortex and cerebellum of APP/PS1 mice, a model for Alzheimer's disease by pioglitazone, a peroxi-some proliferator-activated receptor gamma (PPARγ) agonist. Mol Neurobiol. 56:7267–7283. 2019. View Article : Google Scholar : PubMed/NCBI

39 

Yap K, Mukhina S, Zhang G, Tan JSC, Ong HS and Makeyev EV: A short tandem repeat-enriched RNA assembles a nuclear compartment to control alternative splicing and promote cell survival. Mol Cell. 72:525–540.e13. 2018. View Article : Google Scholar : PubMed/NCBI

40 

Furusawa Y, Yunoki T, Hirano T, Minagawa S, Izumi H, Mori H, Hayashi A and Tabuchi Y: Identification of genes and genetic networks associated with BAG3-dependent cell proliferation and cell survival in human cervical cancer HeLa cells. Mol Med Rep. 18:4138–4146. 2018.PubMed/NCBI

41 

Hirano T, Minagawa S, Furusawa Y, Yunoki T, Ikenaka Y, Yokoyama T, Hoshi N and Tabuchi Y: Growth and neurite stimulating effects of the neonicotinoid pesticide clothianidin on human neuroblastoma SH-SY5Y cells. Toxicol Appl Pharmacol. 383:1147772019. View Article : Google Scholar : PubMed/NCBI

42 

Sarge KD, Murphy SP and Morimoto RI: Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress. Mol Cell Biol. 13:1392–1407. 1993. View Article : Google Scholar : PubMed/NCBI

43 

Todryk SM, Gough MJ and Pockley AG: Facets of heat shock protein 70 show immunotherapeutic potential. Immunology. 110:1–9. 2003. View Article : Google Scholar : PubMed/NCBI

44 

Ito A, Honda H and Kobayashi T: Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: A novel concept of 'heat-controlled necrosis' with heat shock protein expression. Cancer Immunol Immunother. 55:320–328. 2006. View Article : Google Scholar

45 

Deschênes-Simard X, Kottakis F, Meloche S and Ferbeyre G: ERKs in cancer: Friends or foes? Cancer Res. 74:412–419. 2014. View Article : Google Scholar : PubMed/NCBI

46 

Chen F, Rezavi R, Wang CC and Harrison LE: Proteasome inhibition potentiates the cytotoxic effects of hyperthermia in HT-29 colon cancer cells through inhibition of heat shock protein 27. Oncology. 73:98–103. 2007. View Article : Google Scholar

47 

Yunoki T, Tabuchi Y, Hayashi A and Kondo T: BAG3 protects against hyperthermic stress by modulating NF-κB and ERK activities in human retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol. 253:399–407. 2015. View Article : Google Scholar

48 

Czubryt MP, Austria JA and Pierce GN: Hydrogen peroxide inhibition of nuclear protein import is mediated by the mitogen-activated protein kinase, ERK2. J Cell Biol. 148:7–16. 2000. View Article : Google Scholar : PubMed/NCBI

49 

Kosako H, Yamaguchi N, Aranami C, Ushiyama M, Kose S, Imamoto N, Taniguchi H, Nishida E and Hattori S: Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport. Nat Struct Mol Biol. 16:1026–1035. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tabuchi Y, Maekawa K, Torigoe M, Furusawa Y, Hirano T, Minagawa S, Yunoki T and Hayashi A: HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells. Int J Mol Med 46: 58-66, 2020.
APA
Tabuchi, Y., Maekawa, K., Torigoe, M., Furusawa, Y., Hirano, T., Minagawa, S. ... Hayashi, A. (2020). HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells. International Journal of Molecular Medicine, 46, 58-66. https://doi.org/10.3892/ijmm.2020.4591
MLA
Tabuchi, Y., Maekawa, K., Torigoe, M., Furusawa, Y., Hirano, T., Minagawa, S., Yunoki, T., Hayashi, A."HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells". International Journal of Molecular Medicine 46.1 (2020): 58-66.
Chicago
Tabuchi, Y., Maekawa, K., Torigoe, M., Furusawa, Y., Hirano, T., Minagawa, S., Yunoki, T., Hayashi, A."HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells". International Journal of Molecular Medicine 46, no. 1 (2020): 58-66. https://doi.org/10.3892/ijmm.2020.4591
Copy and paste a formatted citation
x
Spandidos Publications style
Tabuchi Y, Maekawa K, Torigoe M, Furusawa Y, Hirano T, Minagawa S, Yunoki T and Hayashi A: HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells. Int J Mol Med 46: 58-66, 2020.
APA
Tabuchi, Y., Maekawa, K., Torigoe, M., Furusawa, Y., Hirano, T., Minagawa, S. ... Hayashi, A. (2020). HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells. International Journal of Molecular Medicine, 46, 58-66. https://doi.org/10.3892/ijmm.2020.4591
MLA
Tabuchi, Y., Maekawa, K., Torigoe, M., Furusawa, Y., Hirano, T., Minagawa, S., Yunoki, T., Hayashi, A."HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells". International Journal of Molecular Medicine 46.1 (2020): 58-66.
Chicago
Tabuchi, Y., Maekawa, K., Torigoe, M., Furusawa, Y., Hirano, T., Minagawa, S., Yunoki, T., Hayashi, A."HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells". International Journal of Molecular Medicine 46, no. 1 (2020): 58-66. https://doi.org/10.3892/ijmm.2020.4591
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team